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Abstract
A kinetics model for cellular repair and misrepair for describing mul-
tiple radiation-induced lesions (mutation-inactivation) is coupled to a two-
mutation model of initiation and promotion in tissue to provide a parametric
description of tumor prevalence in the Harderian gland in a mouse. Dose-
response curves are described/or 7-rays and relativistic ions. The effects of
nuclear fragmentation are also considered for high-energy proton and alpha-
particle exposures. The model described provides a parametric description of
age-dependent cancer induction for a wide range of radiation fields. We also
consider the two hypotheses that radiation acts either solely as an initiator
or as both initiator and promoter and make model calculations for fraction-
ation exposures from "_-rays and relativistic Fe ions. For fractionated Fe ex-
posures, an inverse dose-rate effect is provided by a promotion hypothesis
using a mutation rate for promotion typical of singIe-gene mutations.
Introduction
An understanding of the deleterious biological
effects of space radiation is needed before astro-
nauts are subjected to prolonged exposures to the
high charge and energy (HZE) ion component of
the galactic cosmic rays (GCR). One of the primary
concerns for deep-space flight is the expected can-
cer risk from HZE ions. The nature of the ioniza-
tions in tissue, including the track structure, from
HZE particles is very different from any other type
of radiation to which humans have been exposed,
and thus the expected risk is largely unknown. Al-
though experiments with HZE exposures with cell
cultures are now quite numerous (Thaeker, Stretch,
and Stephens 1979; Yang et al. 1985; Kronenberg
and Little 1989; Kranert, Schneider, and Kiefer 1990;
Lett et al. 1989), only a few experimental stud-
ies (Nelson et al. 1989; Ainsworth 1980; Burns and
Albert 1980) of their mutagenic or tumorigenic po-
tential in animal systems have been undertaken.
The measurements of Fry et al. (1985) and Alpen
et al. (1993 and 1994) for tumor prevalence in the
Harderian gland of a mouse are the most useful of
these studies because the effects on a single tumor
type were considered, and dose-response curves for
several ion species were studied using track-segment
irradiations.
A fairly common view in cancer research is that
the transformation of a single cell will result in tu-
mor formation (Fry and Storer 1987; Land, Parada,
and Weinberg 1983; Renan 1990). The discovery
of oncogenes and the mechanisms for their muta-
tion has resulted in a widely held view of carcino-
genesis for many tumor types as a multistep process
(Renan 1990; Mitchel and Trivedi 1993), involving
initiation, promotion, and progression. The initia-
tion stage would include a set of mutations in the
DNA of the cells produced by a carcinogen resulting
in activation of one or more oncogenes (Renan 1990).
The promotion stage describes the conversion of an
initiated ceil from a premalignant phenotype to a ma-
lignant one, perhaps through the inactivation of a
second type of gene called a tumor-suppressor gene,
and, finally, progression is the stage of more aggres-
sive tumor growth (Renan 1990). V_rhen radiation is
acting as the carcinogen, the type of mutagens may
vary widely. Photon irradiations are observed to in-
volve point mutations (Renan 1990), and we should
expect gross rearrangements and deletions in DNA
to occur following HZE exposures. The GCR spec-
trum imposes further difficulties because of the broad
range of ion velocities and charge number that occur
and because of the protracted exposure encountered
on a long space mission.
Several mathematical models of initiation and
promotion have been developed for phenomenolog-
ical descriptions of carcinogenesis, including mod-
els of natural incidence of cancer (Moolgavkar and
Knudson 1981) and radiation carcinogenesis follow-
ing exposures to radon (Moolgavkar et al. 1990) or al-
pha emitters (Marshall and Groer 1977). The works
of Marshall and Groer (1977) and Moolgavkar et al.
(1990) consider the effects of division and differentia-
tion on initiated cells in order to provide a parametric
description of the age-specific incidence. Models that
undertake similar descriptions of cancer from CCR
exposures must consider the continuum of carcino-
gens entailed in the broad distribution of charge and
energy of these ions and the success of HZE parti-
cles for cell inactivation as observed in cell culture
studies. Dose-responsecurvesfor tumor induction
areoftenparameterizedas(Upton1986)
I=(co+clD+e2D2)e-(blD+b2D2) (1)
where I is the tumor occurrence, D is the absorbed
dose, co is the natural occurrence of cancer, bl and b2
are the linear and quadratic coefficients, respectively,
for high-dose saturation, and cl and c2 are the linear
and quadratic coefficients, respectively. The expo-
nential factor in equation (1) accounts for saturation
or decrease in the occurrence at higher doses which
is often attributed to cell inactivation. The useful-
ness of equation (1) for HZE exposures is severely
limited if methods are not available for determining
the dependence of the parameter on radiation qual-
ity. The track-structure model of Katz et al. (1971)
has been successful in providing a parametric ap-
proach for considering HZE effects with accurate pre-
dictions made for an arbitrary ion species provided
from fits to experimental data for ">rays and a few
ion types. Typically, the Katz model is considered
only for acute exposures. More recently, a model of
linear repair and misrepair kinetics has been devel-
oped by Wilson, Cucinotta, and Shinn (1993) which
includes the Katz action cross-section formalism and
provides a description of temporal effects and the
competition on a cell population between inactiva-
tion and mutations. In this paper, we extend the
kinetics model to include the assumption of initia-
tion and promotion assumption in order to develop
a parametric model of HZE carcinogenesis.
The first purpose of this paper is to provide
a model-dependent formalism that is the age-
dependent analogy of equation (1) which should be
useful for parametric descriptions of GCR effects
based on the success of the Katz action cross-section
model. This presupposes that the description of
Katz for cell damage as described in the terminol-
ogy of grain count, track width, and thindown car-
ries over to cancer in animals from cellular stud-
ies. A second purpose is to consider fractionated
exposures, in particular, the role of cell inactivation
and radiation induction of a second mutation of an
initiation-promotion model.
High-linear-energy-transfer (LET) ions have
shown an inverse dose-rate effect in which fraction-
ated or protracted exposures are often more se-
vere than acute exposures (Ullrich, aernigan, and
Storer 1977; Ullrich 1984). The experiments of
Ullrich suggest that for animal systems, protracted
exposures with high-LET radiations participate in
the promotion stage of carcinogenesis. Exposure
with fission neutrons shows that the inverse dose-
rate effect is tissue dependent as well as dose depen-
dent (Ullrich, Jernigan, and Storer 1977). In cell-
culture studies, synchronization experiments suggest
that a sensitive window in the cell cycle exists (Hill
et al. 1982; Brenner and Hall 1990). However, we
do not know if the same expIanation will be true in
animal systems in which the length of the celt cycle
is typically much longer than that in culture. Fi-
nally, we consider model predictions for temporal ef-
fects for the relative biological effectiveness of high-
energy Fe and protons in which the effects of nuclear
reactions or target fragments are included. In partic-
ular, we consider any age dependence on the relative
biological effectiveness.
In the remainder of this paper, we first review the
kinetics model of multiple-radiation-induced lesions
and repair and misrepair of the lesions, including the
introduction of the track-structure model. We next
introduce a basic model of growth kinetics for ini-
tiated cells and obtain expressions for tumor preva-
lence. Dose fractionation is then considered in our
model, including the possibility of radiation induc-
tion of a mutation that we associate with the pro-
motion stage of carcinogenesis. Finally, we discuss
fits to the experiments for Harderian-gland-tumor
prevalence and discuss model predictions for dose
fractionation.
Kinetics Model for Initiation
A kinetics model for cellular repair and misrepair has been developed by Wilson, Cueinotta, and Shinn (1993)
that includes multiple-lesion formation and is based on first-order repair kinetics. First-order kinetics models
have been considered previously by Dertinger and .lung (1970) and Dienes (1966) for survival curves following
photon exposures. This development of Wilson et al. includes multiple-lesion types, such as those related to
cell inactivation and mutation, and utilizes the track-structure model of Katz et al. (1971) for modeling the
lesion-formation rates for charged particles. We note that other forms of enzyme kinetics, including zeroth
order, second order, or mixed orders, can be considered. The use of first-order kinetics offers at least the
simplicity of analytic solutions and provides a parametric framework.
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Thekineticsmodelassumesthat nascentlesionsareactivechemicalspeciesproducedin fastprocessesby
radiation. The activechemicalspecies,alsodenotedassubstrates,areacteduponby enzymesin the cell
andeventuallyrepairto their originalstateor aremisrepairedandleft in a permanentdamagedstate. The
fixationof thenascentlesionsisassumedto occuroveratimescaleof minutesto hoursandto followfirst-order
kinetics.Asiswellacceptedin radiationbiophysics,wehavetwodistincttimescales,oneforthe initial events
andanotherfor the subsequentialfixationof lesions.Theuninjuredpopulationof cellsat time t is denoted
by no(t). The number of cells at time t with locus I damaged with a number i of lesions is denoted by nli(t).
The production of thesc lesions by radiation is described by rate constants kl_, which will be dependent on
radiation type (for example, the charge and velocity of an ion). The ability of the cell to repair damage leads
to a rate of repair of the nli denoted Ctrli, and if the active species are stabilized but left in a misrepaired state,
a misrepair rate OLmli Occurs. (The rates for lesion formation and repair and misrepair are in units of inverse
time.) The balance equations for the time development of cell populations in a single phase of the cell cycle
are then given for the uninjured population (Wilson, Cucinotta, and Shinn 1993) as
for a locus left in a misrcpaired state as
ri0(t) = Z arli nli(t) - k no(t) (2)
li
¢tl(t ) ----_ aml i nli(t ) + _ arl, i, nll,i,(t ) -- k nl(t )
i lPi I
and for the number of cells with l and i as
i-I
nli(t) = E art'i' nlil'i'-(t) + kli no(t) + E kli-J nlj (t) - knli(t) - all nli(t)
lri I j=l
(3)
(4)
k = E kli (6)
li
We consider only the mutation or mutations at the loci associated with initiation with those cells left
permanently fixed in this statc denoted by hi(t). In order to proceed, loci associated with clonogenic death
must be considered because the mutation phenotype must be expressed in a hereditary fashion. The radiation
induction rates associatcd with clonogenic death are denoted by kdi with
= (7)
i
The radiation induction rates associated with the initiation mutation are denoted by kii with
kI=EkIi (8)
i
The solution of rate equations (2)-(8) for acute exposures follows if we exploit the time scales for thc fast
radiation processes and subsequent fixation. Convergence in the dose range below 10 Gy is achieved for i _< 3,
and we assume a value of 3 for both clonogenic death and mutations. The solution for survival after repair is
complete (Wilson, Cucinotta, and Shinn 1993) and is given by
[ / ,1no(t) = n0(0) e-kdtr + E ardi' ndi'(tr)+ _ arli + O%di' niidi,(t r (9)
ir=l O_dir _=1 \ O_li -_ O_dir
3
and
In equation (4), nlil,i,(t ) denotes the cells with lesions at two loci which obey similar rate equations, and we
define
c_a = c_Tzi+ _mti (5)
and for initiation by
rn_-I ardi' _, ,] 1 [
where rn d = 3, m I = 3, tr is the duration time of the exposure, and where
m d- 1 °_rdil ._ ._1
+ i'=lE -_dilnlidi'(_r)_
(10)
no(tr) = no(O) e -ktr
ndl (tr ) ----kdl tr no(O ) e -ktr
nd2(t_ ) = kd2t r + _._dl_jno(O) e -kt_
1 3 3
nd3(tr) =(kd3tr + 2 kd2kdlt2r + _kdxtr)no(O)e -ktT
nil (tr) = klltr n0(0) e -ktr
,z._2(tr) = kr2tr + 2!,m_T]no(O)
2 2
nIldl(tr) = _.kllkdlt r n0(0) e -ktr
3 2 3 "+
3 2 3
nI2d1(tr) = ( 2 kdl kI2t2 + _.kIlkdltr)no(O) e -ktr
(11)
The possibility of radiation acting as both initiator and promoter suggests the treatment of two specific
mutation typcs. In the experiments studying tumor formation in the Hardcrian gland of a mouse (Fry
et at. 1985; Alpen et al. 1993 and 1994), animals are exposed at about 100 days and we should expect few
cells already initiated for radiation to act upon. For fractionated exposures, the number of initiated cells will
increase through radiation as well as division, and we will include a second mutation related to promotion
which we describe below. We next discuss the treatment of track structure following Katz et al. (1971) in the
kinetics model.
Track-Structure Model for Lesion Formation
The lesion-production coefficients in the kinetics model must include track-structure effects in order to
describe HZE exposures. The model of Katz has been successful for many years in providing a parametric
description of track structure and is used here to model the lesion-production rates. In the Katz model,
biological damage from fast ions is assumed to be caused by secondary electrons (&rays) produced along the
path of the ion. The effects caused by energetic ions are correlated with those of "7-rays by assuming that the
response in sensitive sites near the path of the ion is part of a larger system irradiated with w-rays at the same
dose level. The action cross section is the probability of single-particle (inactivation) activation or mutation
and is calculated by integrating the _/-ray probability function over the radial path of the ion as
fTM
a = 2_r]0 bdbP(b) (12)
where b is the radial distance from the ion to a sensitive site of characteristic size ao, TM is the maximum &ray
range, and P(b) is a probability function for _-ray response assumed to be of the multitarget or multihit form.
Forexample,in themultitargetmodel,
(13)
wherem is the target number, Do is the "y-ray radiosensitivity parameter, and D(b) is the average dose at
the sensitive site. The cross section calculated in equation (12) is observed to plateau at a value a0, which
is indicative of an effective damage area inside the nucleus. The cross section is observed to rise above the
plateau value for stopping ions, which is referred to by Katz et al. (1971) as the track-width regime, and then
to fall to zero, which is referred to as thindown. (See Katz, Dunn, and Sinclair 1985). For relativistic ions of
moderate charge, a < or0, and this is called the grain-count regime. In the track-structure model, a fraction
1 - (a/ao) of the fluence of the ion is assumed to be available to act through intertrack effects in a manner
similar to "y-rays, and the gamma-kill dose of the ion is defined as
with D, = 0 if a > a0, and D is the absorbed dose. In the grain-count regime, the action cross section is
conveniently parameterized as
a= _r0 (1- e-Z*2/_fl2) rn (15)
where Z* denotes the effective charge of the ion, fl denotes the velocity, and n is related to the parameters D O
and a0 through
Doa_ × 1011
- (16)
C
where Do is given in Gy, a0 is given in cm, and C is a constant that defines the average dose deposited in an
extended target by an ion passing through that target. In the earlier work following the radial-dose model of
Butts and Katz (1967), the constant C was set at 2. More recently, Chunxiang, Dunn, and Katz (1985) have
considered a more accurate range-energy relationship for the maximum range of 6-rays. Using this model of
radial dose, we find that C _ 0.7, which effectively reduces the radius a0 of the target by about 60 percent
from earlier results using the Katz model.
The lesion-induction coefficients of the kinetics model are matched to the Katz model by Wilson, Cucinotta,
and Shinn (1993) through the choices
ki3t r = crlF (17)
kd3t r = adF (18)
where F is the fiuence of the ion, ai and ad are thc action cross sections for cell initiation and inactivation,
respectively, and
kzltr = 61/3D______/
D°À I (19)kdl tr -_ 61/3 '_-_d
Dod
with all other values of k set to zero. The choices in equations (17)-(19) assume that 7-rays achieve only a
single step, ki1 or kdl, whereas ions are capable of transition to the unrepairable states with a probability
of kt3 or kd3. For low-LET ions at high energies, the effects of target fragments must be included, and this is
achieved by summing over the energy spectrum of all secondary ions as described by Cucinotta et al. (1991).
Summary of Parameters for Initiation Kinetics
- In order to clarify the number and meaning of parameters introduced in the kinetics model, we briefly
summarize these. For describing the dose-response curves for "y-rays, a radiosensitivity parameter denoted
by DO is used with a distinct parameter for initiation (DoI) and survival (Dod). Repair rates and efficiencies
also occur in the kinetics equations. For acute exposures and for fractionated exposures with interfractionation
times much longer than the time scale of repair (>i day), only the repair efficiencies occur in the dose-response
equations. In the model the cells that have sustained three or more nascent lesions are left fixed (repair
efficiency is zero) as initiated cells or inactivated cells. This leaves two repair efficiencies as parameters with
values between zero and unity which are denoted by O_rdl/O_dl and O_rd2/Old2 for cell survival and by O_rI1/_I1
and O_ri2/o_i2 for initiation. The misrepair efficiencies are then determined as unity minus the repair efficiency.
The repair efficiency for cells with one lesion is most important for fitting the dose-response curve, and this
together with Do determine the initial slope of the 7-rays (Wilson, Cucinotta, and Shinn 1993), which is zero
for 100-percent repair efficiency.
For describing the response to track-segment irradiations with charged ions, wc also require action cross
sections for both the cell inactivation and the initiation mutation. These are modeled by using the parametric
track-structure model of Katz. Here, the response for any charged ion is determined from a knowledge of the
radiosensitivity parameter for ")'-rays for the identical end point, the average radial dose in a sensitive volume
of radius a0, and an effective target area c_0 that encloses the sensitive volumes. By using equation (12), the
action cross sections are then determined by fitting the values a0 and a0 to a data set as described by Katz
et al. (1971). The cross sections for survival and initiation are distinct and result in two new parameters aOd ,
aoi and aOd, aOl for each end point which are fit to dose-response curves. In practice, equation (15) is used
for particles in the grain-count regime, with the result that the parameter _ is used as the fitting parameter
and a 0 is then determined by equation (16). For mixed-radiation fields (i.e., to include the effects of target
fragments produced by high-energy ions), the contributions from all nuclear secondaries are summed to define
an effective cross section as described by Cucinotta et al. (1991).
Growth Kinetics and Tumor Prevalence
In the two-mutation model of initiation promotion, the number of initiated cells must be specified as a
function of tissue age. Here, the effects of division and differentiation of initiated cells are important for
describing age-response curves (Moolgavkar and Knudson 1981). For describing the natural incidence, the
kinetics equation for the normal cell population is assumed to be
 0(t) = (-lal - 30 + 70)n0(t) (20)
where laI is the natural rate of initiation,/J0 is the rate of cell loss, and 70 is the rate of cell division with all
rates in units of day -1. The initiated cell population (hi(t)) is determined by
= la!  o(t)-(lap + -  Dn (t) (21)
where lap is the natural rate of promotion, _i is the rate of cell loss for ni, and w,i is the rate of division of
initiated cells. The time rate of change of promoted cells is given by
 p(t) = lap w(t) (22)
The rates for initiation, promotion, division, and cell loss in equations (20)-(22) may have some time
dependence; however, they are assumed to be constant here. For the normal cell population, we will assume
that most of the cells are quiescent (i.e., in the Go phase) and that losses are small, such that
no(t) = se -t_It _ s (23)
where the initial population is denoted by n0(0) = s. The solution for the initiated population with the initial
condition n I(0) = 0 is then
6
ni(t) = ttlS [exp(7i - j3i - ttp)t - exp(-plt)] (24)
"_I - iI + #I - #P
For _/I -/3/>> #I or gp, the rate of growth is controlled by "_I - flI.
The tumor prevalence is scored as the number of animals in which a neoplasm is found divided by the
number of animals at risk at time t. In the kinetics model, the number of promoted cells is determined by
equation (22) from which we define the hazard function (Marshall and Groer 1977) or rate of appearance of
tumors as
h(t) =  p(t
where g is the minimum tumor growth time, which is some
prevalence is then given by
Y
1 - exp(-P(t)= \
- g) (25)
minimal time necessary for observing a tumor. The
9_0t h(t) dt) (26)
We next include the effects of radiation induction of initiated cells for the case of acute exposures. The
time scale of induction of lesions by radiation is certainly less than a fraction of a second. Enzymatic repair
and misrepair of the lesions are observed to be complete in a few days, although for cancer induction, the state
of knowledge is not well known. The kinetics of tissue growth will occur over a much longer time, perhaps
many days, and we assume that the differences in time scales of these kinetic processes are such that they may
be treated independently in a sequential manner. The effects of radiation and repair on no(t) and nl(t) are
given by equations (8) and (9), respectively. By letting tr be the time of exposure, n0(tr ) and ni(tr ) be the
number of normal and initiated cells immediately after exposure and repair are complete, respectively, and
having irradiation occur early in the animal's lifetime, we find that
=
#IPP no(tr)
_/I --/3I + #I -- PP
{exp[("yi -/31 -- #pXt -- tr)]
x exp(-pltr)- exp(--/_it)} + >p nI(tr) exp[(71 -- _qI - pp)(t - tr)] (27)
The second term in equation (27) thus represents radiation-induced, initiated cells. An important question
for modeling is whether radiation significantly modifies the growth of initiated cells. Here, we use the growth
constant YI - II from natural-incidence curves as a first estimate. Radiation will initially cause a blocking of
progression through the cell cycle; however, the delay time should be small compared with the length of time
elapsed before the observation of cancer, which is usually several hundred days. We note that experimental
studies with _/-rays and neutrons show similar slopes for age versus incidence with the time of appearance
shortened for high-LET radiations (NCRP 1990). _Vc also note that the solutions given above for tumor
prevalence versus time rely only on the combination "fl -- ill, and not on these parameters individually.
Results for Fluence-Response Curves
Tumor prevalence in the Harderian gland of B6CF1 female mice after radiation exposure has been measured
(Fry et al. 1985; Alpen et al. 1993) using pituitary hormones to increase the rate of expression. The exposures
included y-rays and several relativistic ions. Animals were exposed at an age near 100 days and were sacrificed
at 600 days. The initial number of cells is about 5 × 106 per gland with a nuclear diameter of about 5.5 #m
(according to a private communication with Fry in 1992), and we have assumed that about two-thirds of
the cells are susceptible, with the result that the initial cell population is estimated at s = 2/3 × 5 × 106. In
figure 1 (see the dotted-line curve) we have fit the model of equation (26) to the data for natural incidence
with pituitary isografts. The data arc from Fry et al. (1985) and from a private communication with Fry in
1992, and the curves represent the choice for the parameters that are listed in table 1. The minimum growth
time was set at 100 days with results not very sensitive to choices up to about 200 days. The limited amount
of data was not sufficient to rigorously define the parameters; however, they are constrained to within about a
factor of 2 for the model under study.
Tablet. ModelParametersforHarderianGlandTumors
(a)Natural-incidenceparameters
Pl, per day ............................... 1 x 10.7
#p, per day .............................. 1 x 10 .7
"_t - fit, per day ............................ 6 x 10 .3
(b) Radiation-induction parameters
End points o'o, cm 2
Survival ......... 3.2 x 10 -7
Initiation ........ 7.6 x 10-l°
x m Do, Gy
550 3 3.2
480 3 148.0
(c) Repair efficiencies
Values of ari/ai for -
End points i = 1 i = 2
Inactivation ..... 0.999 0.5
Initiation ...... 0.995 0.5
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Figure 1. Prevalence plotted against age of mice at risk for
Harderian glad tumors using pituitary" isografts.
In figure 2, fits to the data of Alpen et al.
(1993) for tumor prevalence using equations (25)-
(27) and (10) are shown versus particle fluence. An
LET value of 0.23 keV/#m is assumed for _-rays. A
summary of the ion types and their energies and lin-
ear energy transfers are given in table 2. Calculated
values are also given in table 2 using equations (12)
or (15) for the action cross sections for cell inacti-
vation and initiation with the fitted parameters for
radiosensitivity and action cross sections in table 1.
The repair efficiencies are also listed in table 1. The
error bars in figure 2 denote the standard deviations
of the prevalence reported by Alpen et al. (1993).
Overall, the agreement with the data is good for all
but two data points fitted to within the experimental
95-percent confidence intervals (Alpen et al. 1993).
For the 1H and 4He exposures, the effects of target
fragmentation were included following the method
described by Cucinotta et al. (1991), and their contri-
butions to a are listed in parentheses in table 2. The
target fragments represent a substantial increase in
the prevalence as compared with the "y-ray response
for these low-LET ions, as can be seen in figure 2(a).
The 4He response, however, is underpredicted at the
higher fluences. The present model offers no expla-
nation for the differences seen between 1H and 4He at
large fluences. The model predicts and the data sug-
gest a turn-down in the prevalence at large fluence
for 4He which we attributed solely to cell killing,
thus reducing the number of target cells available for
initiation.
For the Nb exposure, the cross section is calcu-
lated through integration over the radial distance
using equation (12) because the fit equation is not
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Figure 2. Prevalence of Harderian gland tumors at age of 600 days plotted against particle fluence. Experimental data are taken
from Alpen et al. (1993). Error bands represent standard deviations.
Table2.RadiationTypesandActionCrossSectionsofTumorPrevalenceinHarderianGland
Radiation
type
1H
4He
2ONe
56Fe
56Fe
93Nb
Energy,
MeV/amu
25O
228
670
6OO
350
600
LET,
keV/#m
0.4
1.6
25
193
253
464
aI, cm 2
(a)
1.3 x 10 -16 (5.0 x 10 -14 )
9.7 x 10 -15 (1.0 x 10 -13 )
1.5 x 10 -11
5.4 x 10 -1°
6.5 x 10-1°
1.0 x 10 -9
3.6 x 10 -14 (1.9 x 10 -11)
2,7 x 10 -12 (3.8 x 10 -11)
4.5 x 10 -9
2.0 x 10-7
2.5 x 10-7
5.0 x 10 -7
aValues in parentheses represent target-fragment contributions.
Table 3. Cellular-Response Parameters for Survival in Mammalian Cell Lines
Cell type _ro, cm 2 n m Do, Gy
Harderian gland .....
C3H10T1/2 .......
V-79 ..........
T-1 kidney cells ......
HeLa ..........
Mouse bone marrow ....
3.2 x 10 -7
5.0 x 10 -7
4,28 x 10 -7
6.7 x 10 -7
5.6 x 10 -7
4.2 x 10 -7
55O
750
1100
75O
1100
50O
3
3
3
2.5
3
2.5
3.2
2.8
1.82
1.7
3.7
0.9
accurate in the track-width regime. %re note that
no reduction in carcinogenic potential is expected
from the highest LET ions for the ions under study
in the present model because of their relatively high
velocities. For stopping ions which have similar LET
as the Nb beam, the model would predict such a
reduction. The parameters obtained for the initiation
cross section (table 2) estimate an effective area a 0
slightly larger than that seen in mutation studies
(Tsuboi, Yang, and Chen 1992) or transformation
studies in vitro (Yang et al. 1985) which suggests
that several genes arc able to act as initiators.
Transplantation studies of Harderian gland cells
from CBA/Cne mice into the fat pads of isogenic re-
cipients were studied by Di Majo et al. (1986) where
in vivo survival curves were measured following X-ray
irradiation. The age of the mice at exposure was ap-
proximately the same as the ages used by Fry et al.
(1985) and Alpen et al. (1993). Although the mice
are of a different strain and the experiments of Alpen
et al. (1993) used a 7-ray source for the reference ra-
diation, we compare their survival measurements in
figure 3 with the model survival curves that result
from our model as given by equation (9). The agree-
ment is good, but the relevance is uncertain for the
reasons stated. Although in vivo measurements (us-
O
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1.00
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_ Di Majo et al. (1986)
_,-- Model of equation (9)
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Figure 3. Survival plotted against absorbed dose in Harderian
glaad tissue. Experimental data are taken from Di Majo
et al. (1986) for CBA/Cne mice using X-ray irradiations.
Error bands represent standard deviations.
ing charged particles) for this tissue are not available,
we note that the cellular-response parameters for sur-
vival listed in table 1 are similar to those fitted by the
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Katz model for many mammalian cell lines, which,
for comparison, are listed in table 3. Cell killing has
an important effect on the tumor prevalence mea-
sured at intermediate and large doses for heavy ions
and cannot be ignored in model predictions of tumor
induction.
Age Effects and Role of Pituitary
Isografts
In figure 1, we have calculated the tumor preva-
lence as a function of age for the 600-MeV Fe ex-
posure at doses of 10 and 64 cGy. Also plotted are
data for a fission neutron (fn) exposure with a mean
neutron energy of 0.85 MeV at a dose of 64 cGy.
Calculations were not performed for the fn exposure
at this time because of the detailed transport analy-
ses required. The similarity in the time development
for Fe and fn is quite noticeable, with the slope of
the model calculations for the prevalence curve for Fe
being more rapid than that of the experiments with
fission neutrons. We noted that an identical slope
could be achieved by using a decrease in the growth
rate with a corresponding increase in the spontaneous
promotion rate. The comparison in figure 1 sug-
gests that using the value 3'/- _I = 6 x 10 -3 per day
fitted to the natural-prevalence curve for radiation-
induced tumors is fairly accurate for the system un-
der study. The use of pituitary hormones is expected
to increase the growth parameter _/I- fl! over the
natural rate in the two-mutation model. Exposures
were also performed for Fe (Alpen et al. 1993) and fn
(Fry 1981) without the use of pituitary isografts. In
both cases, a decrease appeared in occurrence; how-
ever, for the Fe exposures, the decrease was small.
We fit our model to the data of Grahn, Lombard, and
Cranes (1992) for the natural prevalence of Harderian
gland tumors without isografts and found a value of
_I - _I _ 2.7 × 10 -3 per day if we keep #I and pp
fixed as in table 1. The data for Fe without isografts
can be fit in our model with "/I - fl! -- 3.5 x 10 -3 per
day if all other parameters are unchanged.
In figure 4, we show calculations of the relative
biological effectiveness (RBE) for 1H at 250 MeV
56
and Fe at 600 MeV/amu as a function of age for an
excess prevalence of 3 percent. The calculations sug-
gest that for acute exposures, the RBE is sensitive
to age with an RBE increase with age due to the re-
duced role of cell inactivation in achieving a 3-percent
excess prevalence at the later ages for these ions.
Dose Fractionation and Promotion By
Radiation
"Many experimental studies in animals as well as in
cell culture observe an enhancement in oncogenic re-
102 --
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Figure 4. RBE at 3-percent excess prevalence for Harderian
gland tumors plotted against age of mice exposed at
100 days. Model calculations are for 56Fe and ]H.
sponse for protracted or fractionated exposures with
high-LET radiations. This is in contrast to photons
where a sparring effect is observed as the norm. Sev-
eral of the possible explanations for the enhancement
or inverse dose-rate effect include a sensitive phase in
cell cycle, the effects of reduced cell killing for pro-
tracted exposures as compared with acute exposures,
the role of repopulation for tissue systems, and, fi-
nally, the possibility that radiation will act as a pro-
moter of initiated cells. The recent experiments of
Miller et al. (1990) using synchronized C3H10T1/2
cells establish that a sensitive phase exists for the
transformation of cell cultures. For in vivo carcino-
genesis, a large amount of data (Upton 1986; Ullrich,
Jernigan, and Storer 1977; Ullrich 1984) performed
under varying exposure conditions suggest that sev-
eral factors contribute to the inverse dose-rate effect.
In principle, the kinetic equations in equa-
tions (2)-(11) could be extended to include the cell
cycle (Wilson, Cucinotta, and Shinn 1993), as well
as a second mutation type corresponding to promo-
tion which could be interpreted as the activation of
a tumor-suppressor gene. Such an approach would
be cumbersome because of the need for a numerical
solution of the resulting differential equations and be-
cause of the large number of parameters that would
be required. Instead, we will consider fractionated
exposures with interfractionation times longer than
a few days in which analytic solutions are possible
without the addition of many new parameters. This
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allowsusto considerseveralof theproposedexpla-
nationsof the inversedose-rateffectin thepresent
model.
The roles of cell killing and repopulationare
consideredfor afractionatedexposureseparatedby
time intervalsof a fewdaysor moreby sequential
solutionto equations(2)-(4) and (20)-(22). Here,
thenumberofinitiatedcellsfromradiationat timet
after N fractions for the case of no radiation-induced
promotion is
N
hi(t)---- Enl(ti)exp[(71 -- _I -- #PX t - ti)]fi (28)
i=l
where ni(ti ) is the number of cells initiated by ra-
diation in the ith fraction and fi is the fraction of
cells remaining after the ith fraction. To consider
an upper bound on fractionation effects from possi-
ble repopulation between exposures, we also consider
setting fi equal to unity which corresponds to the
case of full repopulation.
V_Te will also consider a second mutation event
corresponding to the promotion of initiated cells in
fractionated exposures. This type of assumption be-
comes important for older ages in which the num-
ber of cells initiated spontaneously will bc relatively
large. Here, the kinetic equation solution follows
from equations (2)-(4) with the introduction of a
second mutation type that is active only in the ini-
tiated cells. If we assume that the populations nI
and np are always small compared with no, we find
that the number of radiation-induced promoted cells
in an N-fraction experiment is given by
N
np(ti______) (29)
ne(t) Z  i(t) n (t)
i=2
where np(ti)/ni(t) represents the fraction of initi-
ated cells promoted by the ith exposure and is given
by equation (10), with the lesion formation rates and
repair rates for promotion used instead of those for
initiation. We estimate these rates in the following
comparisons.
Figure 5 shows four calculations for fractionated
exposures separated by 1 week of 600-MeV/amu Fe
and 7-rays versus absorbed dose. In figure 5(a), we
use equation (28) with no allowance for repopulation
between fractions. Two effects are observed: (1) the
_/-rays show considerable sparring with increasing
number of fractions, and (2) for Fe, a 24-week frac-
tionated exposure also shows considerable sparring
that is due to the initiated cells in the later fractions
having insufficient time to divide before the sacri-
fice at 600 days. In figure 5(b), we allow for full
repopulation between exposures. Again, the "_-rays
show sparring. For Fe, an inverse dose-rate effect oc-
curs for the two- and six-fraction schedules; however,
for the 24-week schedule, the increase is seen only
above 0.8 Gy with sparring again at the lower dose
levels. The inverse dose-rate effect seen in fission neu-
tron exposures for many tumor types shows a con-
tinued increase for even 60-week schedules (Grahn,
Lombard, and Cranes 1992). Because wc also do
not expect full repopulation to occur, we expect that
figure 5(b) does not account for the enhancement
anticipated.
In figure 5(c), we include a second mutation rate
from equation (29) and have all lesion formation
parameters set equal to those used for initiation.
A large enhancement is now seen for the fraction-
ated exposures with a decrease for v-rays again.
With the fractionation combined with the mutation
rate, we have assumed that the second mutation
accounts for an inverse dose-rate effect. As a fi-
nal estimate, we have considered calculations in fig-
ure 5(d) in which the promotion lesion is assumed
to be similar to the HGPRT (hypoxanthine guanine
phosphoribosyl transferase) mutation as estimated
in our mutation model from the data of Tsuboi,
Yang, and Chin (1992) and Thacker, Stretch, and
Stephens (1979). Here CrOp _--- 0.9 × 10 -10 cm 2 and
Dop _ 1000 Gy. For this very specific gene muta-
tion, the enhancement is seen, although it is less sig-
nificant than it would be if the promotion mutation
rate were near that of initiation.
In space, the dominant radiation component is
high-energy protons in which a flux of about 2 × 10s
protons/cm2/year is expected. Because these pro-
tons will produce _tn appreciable number of high-LET
secondaries, we consider if an inverse dose-rate ef-
fect will occur for protracted exposure. In figure 6,
we show calculations for 250-MeV protons using the
model of figure 5(c). A large enhancement is seen
above doses of 0.5 Gy, which is close to the expected
dose on an extended space mission.
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Figure 5. Model calculations of dose fractionation for Fe at 600 MeV/amu and ?-rays. Interfractionation times are 1 week.
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Figure 6. Model calculations of dose fractionation similar to
figure 5(c) for 250-MeV protons.
Concluding Remarks
By using the hypothesis that carcinogenesis in
mice occurs through two mutational steps, we have
developed a parametric model of radiation carcino-
genesis for charged particles. The number or type of
mutations required for cancer induction is not well
known and is certainly not unique. By assuming
a two-mutation model with clonal expansion of ini-
tatied cells, the age dependence of natural occurring
tumors can be fitted, and the possibility of radiation-
induced promotion can be explored. The model pro-
ceeds from the kinetics of lesion formation and repair
and misrepair for the mutation and survival of cells.
The use of linear-repair kinetics provides an analytic
framework to consider dose-rate effects. However,
many important questions regarding the kinetics of
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enzymatic repair have not been considered, and these
may become important in extrapolating a parametric
model to low fluences. Track-structure effects have
been introduced into our model through the use of
the radial-dose formalism of action cross sections de-
veloped by Katz. The resulting parameterizations of
action cross sections for mutations and inactivation
as a function of charge and velocity of an ion allows
for predictions for any monoenergetic or mixed field
of radiation for which the particle-fluence spectrum
is known.
A two-mutation model of the natural incidence
of carcinogenesis requires rates for spontaneous pro-
duction of the first and second mutations, as well
as the rate of clonal expansion of the initiated cells
that carry the first mutation. We have estimated
these rates by using the natural-incidence curves for
Harderian gland tumors in mice that have received
pituitary isografts. The kinctics of radiation-induced
mutation were coupled to the model of the natural
incidence of cancer. For mice having acute exposures
early in their mature life, we have assumed that the
rate Of expansion of initiated cells is close to the spon-
taneous rate. This assumes that the rate does not
change appreciably with radiation type or damage
level and that radiation-induced blocking of the cell
cycle has only a small effect on the expansion sev-
eral hundred days after the administration of radia-
tion. The resulting model was fitted to dose-response
curves for Itarderian-gland-tumor prevalence in mice
near 600 days in age. The cross sections for inactiva-
tion and the mutation associated with the initiation
event determined from our fits are of the same order
of magnitude as those observed in many experiments
with cell culture. For high-energy protons and alpha
particles, the addition of the effects of the target frag-
ments produced in nuclear reaction accounted for the
increase in tumorigenic potential seen at low dose as
compared with 7-rays. The large differences seen in
the experiments between protons and alpha particles
at high dose could not be explained in our model.
An enhancement in onconogenic effect following
protracted exposures to high-linear-energy-transfer
(LET) radiation has been observed in many stud-
ies in animals and cell culture. By using our ap-
proach, we have considered several factors that could
lead to such an effect, including cell killing, repopu-
lation, and radiation-induced promotion of initiated
cells. The effects of repopulation were seen to lead
to an enhancement for a small number of fractions
for relativistic iron nuclei; however, for a large num-
ber of fractions, the enhancement was not seen be-
cause of insufficient time for expansion of initiated
cells. The addition of a second mutation induced by
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radiation associated with the promotion of initiated
cells also leads to an inverse dose-rate effect in the
present model. The enhancement using this assump-
tion would be very large if the action cross section
for the second mutation was about the same as that
of the first mutation, or it would be more modest
if the cross section was close to the observed muta-
tion rates in mammalian cells for the HGPRT locus.
In all cases considered, the effects of "_-rays are re-
duced through dose fractionation. In contrast, an in-
verse dose-rate effect is seen for high-energy protons
when radiation is assumed to act as a promoter be-
cause of the high-LET component of their effect from
nuclear reactions. This effect could have important
consequences for space radiation protection.
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